Endpoint Health Stock

Endpoint Health is a biotechnology company that develops precision medicine and integrated therapies for critical care. The company's precision approaches to deeply understanding patients' immune states and using that knowledge to develop precision therapies are exactly the type of innovation needed. To develop precision therapies for patients with immune-mediated conditions such as acute respiratory distress syndrome (ARDS), sepsis, rheumatic and gastroenterologic diseases, researchers are combining therapeutics, therapy-guiding tests, and AI. Endpoint Health was built from the ground up to develop and commercialize therapeutics and therapy-guiding tests, ensuring that every patient receives personalized care that significantly improves their outcomes.